Corporate ActionSep 10, 2026, 04:39 PM
NewGenIvf Group Ltd Files for Offering of Up to 5.45M Shares
AI Summary
NewGenIvf Group Ltd has filed an F-1 registration statement for a proposed offering of up to 5,454,545 Class A Ordinary Shares at $1.10 per share, alongside pre-funded warrants. Additionally, selling securityholders intend to offer up to 4,364,044 Class A Ordinary Shares. The company, an assisted reproductive services provider in Asia-Pacific, reported revenue of US$4.73 million and a net income of US$9.73 million for the year ended December 31, 2025, a significant turnaround from a net loss of US$0.47 million on US$5.43 million revenue in 2024. The filing also details the company's history, including multiple reverse stock splits and its business operations in Thailand, Cambodia, and Kyrgyzstan.
Key Highlights
- NewGenIvf Group Ltd is offering up to 5,454,545 Class A Ordinary Shares at $1.10 per share.
- The company is also offering pre-funded warrants in lieu of shares for purchasers exceeding beneficial ownership limits.
- Selling securityholders plan to offer up to 4,364,044 Class A Ordinary Shares from convertible promissory notes.
- The company has undergone multiple reverse stock splits, with the latest being a 1-for-3 split on September 1, 2026.
- NewGenIvf Group Ltd is an assisted reproductive services (ARS) provider in Asia-Pacific, with operations in Thailand, Cambodia, and Kyrgyzstan.
- The company generated US$5,433,375 in revenue and a net loss of US$(474,101) for the year ended December 31, 2024.
- For the year ended December 31, 2025, revenue was US$4,726,433 and net income was US$9,728,723.
Price Impact
More from NIVF